We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for... Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Show more
-- Navenibart Demonstrated 6 Months of HAE Attack Prevention with 1 or 2 Doses -- -- 90-95% Mean Monthly Attack Rate Reduction Supporting Chronic Dosing 2 or 4 Times Per Year -- -- 67...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 32,500...
-- Navenibart (STAR-0215), the Potential Market-Leading Therapy for the Treatment of Hereditary Angioedema, on Track for Expected Phase 3 Initiation in Q1 2025 -- -- Final 3- and 6-Month Results...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that Jill C. Milne...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.59 | -6.1780104712 | 9.55 | 9.63 | 8.7589 | 341796 | 9.4423364 | CS |
4 | -1.58 | -14.990512334 | 10.54 | 11.01 | 8.7589 | 397985 | 9.78074516 | CS |
12 | -2.89 | -24.388185654 | 11.85 | 12.515 | 8.61 | 286264 | 10.37831483 | CS |
26 | -0.22 | -2.39651416122 | 9.18 | 12.92 | 8.61 | 338260 | 10.85994204 | CS |
52 | 1.41 | 18.6754966887 | 7.55 | 16.9 | 6.58 | 584400 | 11.5836474 | CS |
156 | 3.72 | 70.9923664122 | 5.24 | 16.9 | 2.36 | 316676 | 10.46971715 | CS |
260 | 0.43 | 5.04103165299 | 8.53 | 16.9 | 2.36 | 292704 | 10.41139675 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions